Discover how to buy shares of Kala Pharmaceuticals (KALA) Step by step in english

kala pharmaceuticals

Kala Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company’s product candidates include EYSUVIS for the short-term treatment of signs and symptoms of dry eye disease; and INVELTYS, a twice-daily topical ocular steroid for the treatment of postoperative pain and inflammation after eye surgery. Its preclinical development programs include KPI-285/KPI-286, a receptor tyrosine kinase inhibitor program for the treatment of various retinal diseases; The SEGRM program, a new class of compounds designed to regulate gene expression through the transrepression pathway by bypassing the transactivation pathway; and the surface targeted steroid program (KPI-333), a new chemical entity as a topical steroid that targets the ocular surface. The company was previously known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.

Discover how to buy shares of Kala Pharmaceuticals (KALA) Step by step in Spanish

Would you like to buy Kala Pharmaceuticals (KALA) shares on Nasdaq in a simple way and using a regulated and quality broker? Does it call your attention to be able to invest your profits from the bank and get a return on the stock market? Today I am going to show you how you can invest in DEGIRO , a reliable Dutch investment broker with low commissions, and how you can get Kala Pharmaceuticals, Inc. (KALA) (KALA) shares quickly and intuitively.

The tutorial is easy to follow :

  • First of all we are going to register in DEGIRO, a broker platform where we are going to acquire shares of the company Kala Pharmaceuticals, Inc. (KALA) – (KALA).
  • We will now enter funds to execute the first investment in the stock market.
  • When we see the funds in our account, we must locate the company Kala Pharmaceuticals through its TICKER, which is KALA.
  • Then we will only have to add the number of shares that we are going to buy, the price at which we will buy them and the type of order.

The summary may have been basic for you, so I am going to show you the procedure with images of each part:

Tutorial to register in DEGIRO

The first step is to register in DeGiro through the following link :

buy shares of Kala Pharmaceuticals, Inc. (KALA)

It will ask us for an email, a username and a PIN code to enter, and then we must continue using the link that they have sent us by mail.

DEGIRO will continually ask us for some important information to accept that it is us . We will need to have in hand the number of the passport, national identity document or driving license, the mobile and the number of the bank account that we are going to use to make our 1st deposit. If you do not understand what this format is, you can review this simple tutorial that we have done at .

stock Kala Pharmaceuticals

Once our account is accepted we will be able to enter money from the Enter / Withdraw section. We can make a transaction that will take between 2-3 days, or make the deposit quickly using Sofort, a truly secure and reliable payment gateway.

deposit money Kala Pharmaceuticals

How to buy Kala Pharmaceuticals (KALA) shares via degiro

Once we have the money we can buy our first share. You can use the “Place Order” button in the right corner or select the DEGIRO search engine and type in the ticker. In the next screenshot you will see that I have used the Amazon Ticker but in your case you have to enter (KALA), the Kala Pharmaceuticals ticker. As it is an action, we will see that the related results are listed and there we will see Kala Pharmaceuticals. What is key is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Kala Pharmaceuticals, Inc. (KALA) is listed on Nasdaq. This step is important so make no mistake.

American bag opening Kala Pharmaceuticals

When developing the order we will pay special attention to the following . We may place a limit or market order. Think that you plan to buy a share of Kala Pharmaceuticals, but its true price is much higher. With this limit order we will place the value at which we plan to make the acquisition and until there are no shares selling at that price, the purchase of the share will not be carried out. With a market order, DeGiro will buy the number of shares we have indicated at the true selling price, which would be very close to today’s trading price.

limited order expansion Kala Pharmaceuticals, Inc. (KALA)

In all cases it is essential that you look at the order: permanent or of the day . To serve as an example, in Spain, the stock market price is in the morning and until 1:00 p.m., and in the US it corresponds to the afternoon schedule in Spain. If the order is fixed, it will be maintained until the point in which it is executed, but if you choose the «of the day» option, at the time the session on the stock market ends, if it has not been carried out, it will be deleted from your history in Activity – Orders in process.

I want this simple text to have helped you to buy shares in Kala Pharmaceuticals.

  Company information
  • Kala Pharmaceuticals, Inc. (KALA) Address: 490 Arsenal Way Suite 120 Watertown, MA 02472 United States 781996 5252 – Website:
  • Ticker: KALA
  • Industry: Unknown
  • Industry: Unknown
  • Number of employees: 188
  • Listed market: Nasdaq

key executives

Name Title Salary exercised Year of birth
Mr. Mark T. Iwicki Chairman, President and CEO 1.27 million N/A 1966
Mr. Todd Bazemore Director of operations 739.54k N/A 1970
Dr Kim Brazzell Medical director 848.27k N/A 1953
Dr. Justin Hanes Ph.D. Founder and Chairman of the Scientific Advisory Council N/A N/A N/A
Ms. Mary Reumuth CPA, CPA CFO and Treasurer N/A N/A 1975
Dr Hongming Chen Sc.D. Scientific Director N/A N/A 1971
Mrs. Jill S. Steier Exec. Director of Investor Relations and Corporate Communications N/A N/A N/A
Mr. Eric L. Trachtenberg General Counsel, Director of Compliance and Corporate Sec. N/A N/A 1973
Mrs Kathleen McCann Kline Senior Vice President of Marketing N/A N/A N/A
Mrs. Michele LaRussa Senior Vice President of Regulatory Affairs and Quality Assurance N/A N/A 1970

Recent events of :

Recent Events: June 26, 2020. Filed Complete: 8-K: Change of Directors or Principal Officers, Business Submission to May 26, 2020. Filed Complete: 8-K: Other Events: May 07, 2020. Filed Full Filed: 8-K: Results of Operations and Financial Condition, Financial Statements and May 07, 2020. Filed Full: 10-Q: Quarterly Report 08 Apr 2020. Filed Full: 8-K: Regulation FD DisclosureShow All Events